Alessio Gambardella

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy.

Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy.

Journal: Italian journal of dermatology and venereology

Published: September 18, 2023

Are IL-23 inhibitors too slow to have a therapeutic success in plaque psoriasis? A real-life experience of 330 patients.

Are IL-23 inhibitors too slow to have a therapeutic success in plaque psoriasis? A real-life experience of 330 patients.

Journal: Italian journal of dermatology and venereology

Published: June 06, 2023

Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study.

Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 30, 2023

Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series.

Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 13, 2023

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.

Journal: Journal of the American Academy of Dermatology

Published: January 10, 2023

Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.

Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study.

Journal: Journal of the American Academy of Dermatology

Published: September 28, 2022

Down syndrome and biological treatments in dermatology: Efficacy and safety in our real-life experience and review of literature.

Down syndrome and biological treatments in dermatology: Efficacy and safety in our real-life experience and review of literature.

Journal: The Australasian journal of dermatology

Published: September 04, 2022

A case of refractory palmoplantar psoriasis treated with tildrakizumab.

A case of refractory palmoplantar psoriasis treated with tildrakizumab.

Journal: Italian journal of dermatology and venereology

Published: August 02, 2022

Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study.

Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study.

Journal: Drugs in R&D

Published: July 18, 2022

Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study.

Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study.

Journal: Dermatology and therapy

Published: July 13, 2022

A multidisciplinary care unit approach for the management of psoriatic arthritis: an Italian experience.

A multidisciplinary care unit approach for the management of psoriatic arthritis: an Italian experience.

Journal: Italian journal of dermatology and venereology

Published: July 05, 2022

Management of alopecia areata in JAK-inhibitors era: are systemic and topical corticosteroids still useful?

Management of alopecia areata in JAK-inhibitors era: are systemic and topical corticosteroids still useful?

Journal: International journal of dermatology

Published: June 29, 2022

Showing 1-12 of 55

Last Updated: 09/26/2026